Aburano T, Tonami N, Tada A, Hisada K
Eur J Nucl Med. 1980 Aug;5(4):373-6. doi: 10.1007/BF00445625.
The combined tests of serum alpha 1-fetoprotein (AFP) and carcinoembryonic antigen (CEA) were routinely performed in 210 patients with focal hepatic lesions on a 99mTc-colloid liver scan in order to determine whether these could provide more useful information that AFP test alone in the qualitative evaluation of focal hepatic lesions. The predictive value of hepatoma with positive AFP alone remained 80%. However, when the negative CEA was combined with positive AFP, the predictive value of hepatoma (91%) with both was greatly increased. On the other hand, the predictive value of metastatic liver cancer with positive CEA showed 92%. The combined test of AFP and CEA may be useful for preserving high predictive values of hepatoma and metastatic liver disease.
对210例经99mTc胶体肝扫描发现有局灶性肝病变的患者常规进行血清甲胎蛋白(AFP)和癌胚抗原(CEA)联合检测,以确定在局灶性肝病变的定性评估中,联合检测是否能比单独检测AFP提供更有用的信息。单独AFP阳性对肝癌的预测价值仍为80%。然而,当CEA阴性与AFP阳性相结合时,两者同时阳性对肝癌的预测价值(91%)大幅提高。另一方面,CEA阳性对转移性肝癌的预测价值为92%。AFP和CEA联合检测可能有助于保持对肝癌和转移性肝病的高预测价值。